Dexamethasone Mouthwash

Phase 3

WWoman's

Dexamethasone Mouthwash is one of 30 therapeutic programs targeting Oral Mucositis. It is currently in Phase 3.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[2][1]

Indication

Oral MucositisRecruiting

StomatitisRecruiting

Oral MucositisPhase 3

Recruiting

StomatitisPhase 3

Recruiting

Competition

Competitive Landscape

26 competitors in Oral Mucositis

#DrugCompanyPhaseTrials

Thalomid

Bristol-Myers Squibb

Approved

—2

MS Contin

HHikma Pharmaceuticals LLC

Approved

2 3

Alka-Seltzer

AAbbott

Approved

1 4

Levaquin

WWim Janssens

Approved

1 5

Mycostatin

GGood Molecules, LLC

Approved

—6

Acetadote

AArbor Pharmaceuticals, Inc.

Catapres

Heparin Sodium

BBaxter Healthcare Corporation

Approved

—9

Peridex

DDexcel Pharma Technologies Ltd.

Approved

—10

Betadine

BBecton, Dickinson and Company

Approved

—

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q1 2028

ApprovedRecruiting

Oral Mucositis

NCT07287826

ApprovedRecruiting

Stomatitis

NCT07357597

Clinical

Trials by Indication[1]

Stomatitis1 trial

A Phase IV, Open-Label, Single-Arm Study of Prophylaxis for Datopotamab Deruxtecan-related Stomatitis in Eligible Patients With Metastatic or Inoperable Locally Recurrent Breast Cancer or Locally Advanced or Metastatic Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer (TROPION-SWISH)

Recruiting· AstraZeneca logo

AstraZeneca·Approved·NCT07357597·100 enrolled

Oral Mucositis1 trial

Study for Dexamethasone Mouthwash in Lowering Episodes of Oral Mucositis Among Patients With Cancer: The SMILE Study

Recruiting·WWoman's·Approved·NCT07287826·45 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Dexamethasone Mouthwash. U.S. National Library of Medicine, National Institutes of Health.
[2]
Open Targets Platform — Drug–disease associations for Dexamethasone Mouthwash. EMBL-EBI & Wellcome Sanger Institute.
[3]
SEC EDGAR — Woman's company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Highest Phase: Phase 3[1]
Company: WWoman's

Dexamethasone Mouthwash

Status by Indication[2][1]

Competitive Landscape

Expected Milestones

Q1 2028

Trials by Indication[1]

Stomatitis1 trial

Oral Mucositis1 trial

References

Drug Info

Quick Facts

Related News